Upgrade to SI Premium - Free Trial

Lantheus Holdings (LNTH) Tops Q4 EPS by 4c, Revenues Miss; Offers Q1 & FY20 EPS Guidance Above Consensus, Q1 & FY20 Revenue Guidance Below Consensus

February 25, 2020 7:16 AM

Lantheus Holdings (NASDAQ: LNTH) reported Q4 EPS of $0.34, $0.04 better than the analyst estimate of $0.30. Revenue for the quarter came in at $89.3 million versus the consensus estimate of $91.2 million.

“We finished 2019 with robust DEFINITY, earnings and free cash flow performance,” said Mary Anne Heino, President and CEO. “Throughout 2019, it was Lantheus team members from across the organization who drove these results. As we look to 2020 and beyond, we see exciting revenue and value creation opportunities for the Company as we add the Progenics’ team with their exciting oncology, precision diagnostic, and other products to our own portfolio.”

GUIDANCE:

Lantheus Holdings sees Q1 2020 EPS of $0.25-$0.27, versus the consensus of $0.03. Lantheus Holdings sees Q1 2020 revenue of $89-91 million, versus the consensus of $100.98 million.

Lantheus Holdings sees FY2020 EPS of $1.34-$1.40, versus the consensus of $1.03. Lantheus Holdings sees FY2020 revenue of $384-390 million, versus the consensus of $391.92 million.

For earnings history and earnings-related data on Lantheus Holdings (LNTH) click here.

Categories

Corporate News Earnings Guidance Hot Guidance Management Comments

Next Articles